RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Brain Hypoxia-Ischemia
Accession: DOID:9003676
browse the term
Definition: A disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.
Synonyms: exact_synonym: Anoxic Ischemic Encephalopathy; Anoxic-Ischemic Encephalopathies; Brain Anoxia Ischemia; Brain Anoxia-Ischemias; Brain Hypoxia-Ischemias; Brain Ischemia-Anoxias; Brain Ischemia-Hypoxias; Cerebral Anoxia Ischemia; Cerebral Anoxia-Ischemias; Cerebral Hypoxia Ischemia; Cerebral Hypoxia-Ischemias; Cerebral Ischemia-Anoxias; Cerebral Ischemia-Hypoxias; Hypoxic Ischemic Encephalopathy; Hypoxic-Ischemic Encephalopathies
primary_id: MESH:D020925
xref: EFO:1000846
G
ACVR2B
activin A receptor type 2B
severity
ISO
mRNA, protein:increased expression:umbilical cord blood (human)
RGD
PMID:27957679
RGD:329849106
NCBI chr13:23,237,699...23,276,086
Ensembl chr13:23,237,699...23,267,373
G
ADA
adenosine deaminase
ISO
protein:increased activity:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr17:47,044,492...47,072,232
Ensembl chr17:47,044,497...47,072,245
G
ADK
adenosine kinase
ISO
protein:decreased expression:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr14:76,836,072...77,320,586
Ensembl chr14:76,836,095...77,322,416
G
ADNP
activity dependent neuroprotector homeobox
ISO
RGD
PMID:16938277
RGD:2312775
NCBI chr17:52,316,388...52,350,732
Ensembl chr17:52,317,913...52,332,079
G
ADORA1
adenosine A1 receptor
ISO
protein:decreased expression:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr 9:113,835,279...113,875,899
Ensembl chr 9:113,835,921...113,872,365
G
AGTR2
angiotensin II receptor type 2
ISO
RGD
PMID:22569153
RGD:6903872
NCBI chr X:95,267,709...95,272,237
Ensembl chr X:95,269,300...95,270,388
G
AIF1
allograft inflammatory factor 1
ISO
protein:increased expression:right cerebral hemisphere (rat)
RGD
PMID:19447505
RGD:2313021
NCBI chr 7:23,711,752...23,731,191
Ensembl chr 7:23,728,726...23,731,675
G
AIFM1
apoptosis inducing factor mitochondria associated 1
ISO
protein:increased expression:nucleus:
RGD
PMID:12871572 PMID:28108258
RGD:10053564 RGD:13524865
NCBI chr X:106,676,596...106,708,290
Ensembl chr X:106,670,520...106,708,317
G
ARNTL
aryl hydrocarbon receptor nuclear translocator like
ISO
protein:increased expression:pineal gland
RGD
PMID:23336172
RGD:10043348
NCBI chr 2:45,895,637...46,025,174
Ensembl chr 2:45,895,289...45,988,570
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:21189961 PMID:24089674 PMID:29635023
RGD:10054502 RGD:13782292 RGD:155882465
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,147
G
BCAN
brevican
ISO
RGD
PMID:15817274
RGD:14392799
NCBI chr 4:93,432,331...93,450,895
Ensembl chr 4:93,432,330...93,450,831
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:21189961 PMID:24089674 PMID:29635023
RGD:10054502 RGD:13782292 RGD:155882465
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BCL2L1
BCL2 like 1
ISO
RGD
PMID:24195677
RGD:10053669
NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
G
BECN1
beclin 1
ISO
protein:increased expression:cerebral cortex protein:increased expression:brain
RGD
PMID:22449108 PMID:25919564
RGD:11558017 RGD:6483050
NCBI chr12:20,041,914...20,054,249
Ensembl chr12:20,041,956...20,054,373
G
BMP4
bone morphogenetic protein 4
ISO
mRNA,protein:decreased expression:brain:
RGD
PMID:23236544
RGD:8699519
NCBI chr 1:183,415,989...183,422,888
Ensembl chr 1:183,416,146...183,422,637
G
CASP1
caspase 1, apoptosis-related cysteine peptidase
ISO
RGD
PMID:23046993
RGD:13782359
NCBI chr 9:35,188,066...35,199,364
Ensembl chr 9:35,186,420...35,200,328
G
CASP3
caspase 3
treatment
ISO
protein:increased activity:cerebral cortex, hippocampus
RGD
PMID:18603371 PMID:21189961 PMID:23046993 PMID:24089674 PMID:27216999 PMID:29635023 More...
RGD:10054502 RGD:13782279 RGD:13782292 RGD:13782359 RGD:155882465 RGD:2311455
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:23046993 PMID:29635023
RGD:13782292 RGD:13782359
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
G
CASP9
caspase 9
treatment
ISO
RGD
PMID:23046993 PMID:24089674
RGD:13782359 RGD:155882465
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
G
CAST
calpastatin
ISO
RGD
PMID:10318818
RGD:5683321
NCBI chr 2:103,255,738...103,378,623
Ensembl chr 2:103,255,750...103,378,623
G
CAT
catalase
treatment
ISO
RGD
PMID:21978706
RGD:9068474
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CCL2
chemokine (C-C motif) ligand 2
ISO
protein:increased expression:forebrain (rat)
RGD
PMID:9270493
RGD:8549543
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCR2
C-C motif chemokine receptor 2
ISO
mRNA, protein:increased expression:brain
RGD
PMID:18095591
RGD:4144890
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,369,122...29,376,343
G
CCR5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:cerebral hemisphere (rat)
RGD
PMID:16516309
RGD:4890442
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
G
CDK5R1
cyclin dependent kinase 5 regulatory subunit 1
treatment
ISO
RGD
PMID:25665755
RGD:13782373
NCBI chr12:42,456,063...42,494,494
Ensembl chr12:42,493,392...42,494,413
G
CLOCK
clock circadian regulator
ISO
protein:increased expression:pineal gland
RGD
PMID:23336172
RGD:10043348
NCBI chr 8:54,793,323...54,910,192
Ensembl chr 8:54,793,342...54,877,777
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:19747899
RGD:6483337
NCBI chr12:20,758,081...20,765,655
Ensembl chr12:20,758,083...20,765,553
G
CRP
C-reactive protein, pentraxin-related
ISO
RGD
PMID:20220110
RGD:9585994
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
G
CS
citrate synthase
treatment
ISO
RGD
PMID:15132986 PMID:15569775
RGD:243048479 RGD:243048481
NCBI chr 5:21,669,778...21,700,737
Ensembl chr 5:21,666,585...21,700,711
G
CSF1R
colony stimulating factor 1 receptor
exacerbates
ISO
protein:increased expression:right cerebral hemisphere, astrocyte, neuron (rat)
RGD
PMID:32522286 PMID:33101590
RGD:151665765 RGD:151665766
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
mRNA:increased expression:brain
RGD
PMID:17549754
RGD:2311381
NCBI chr X:57,592,032...57,595,706
Ensembl chr X:57,592,038...57,595,692
G
DAXX
death domain associated protein
ISO
RGD
PMID:21843499
RGD:9587791
NCBI chr 7:29,676,854...29,681,145
Ensembl chr 7:29,676,856...29,681,110
G
DNMT3A
DNA methyltransferase 3 alpha
ISO
protein:decreased expression:brain:
RGD
PMID:23716065
RGD:9588620
NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,603,087
G
EGR1
early growth response 1
ISO
mRNA:increased expression:forebrain (rat)
RGD
PMID:7684483
RGD:2289081
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
G
EIF2S1
eukaryotic translation initiation factor 2 subunit alpha
ISO
RGD
PMID:8092984
RGD:10395352
NCBI chr 7:91,085,025...91,109,835
Ensembl chr 7:91,085,335...91,109,827
G
EPHA4
EPH receptor A4
ISO
protein:increased expression:brain
RGD
PMID:21736568
RGD:5688765
NCBI chr15:123,350,867...123,501,872
Ensembl chr15:123,352,816...123,503,126
G
EPO
erythropoietin
treatment
ISO
RGD
PMID:22156696 PMID:24034924
RGD:10400911 RGD:10401072
NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936
G
ERO1A
endoplasmic reticulum oxidoreductase 1 alpha
ISO
mRNA:increased expression:hippocampus
RGD
PMID:12694393
RGD:632668
NCBI chr 1:182,268,651...182,318,147
Ensembl chr 1:182,265,261...182,318,195
G
FADD
Fas associated via death domain
treatment
ISO
RGD
PMID:29635023
RGD:13782292
NCBI chr 2:3,191,718...3,194,820
Ensembl chr 2:3,185,675...3,194,818
G
FAS
Fas cell surface death receptor
ISO
RGD
PMID:21843499
RGD:9587791
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
protein:decreased expression:hippocampus
RGD
PMID:25262910
RGD:405650622
NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554
G
FOXO3
forkhead box O3
ISO
protein:increased expression:cerebral cortex,nucleus:
RGD
PMID:24229603
RGD:10402203
NCBI chr 1:74,626,673...74,760,323
Ensembl chr 1:74,628,218...74,760,325
G
FST
follistatin
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:10415398
RGD:329322882
NCBI chr16:32,806,341...32,811,382
Ensembl chr16:32,805,932...32,811,421
G
GHR
growth hormone receptor
ISO
protein:increased expression:brain
RGD
PMID:19524466
RGD:2315620
NCBI chr16:27,126,300...27,422,618
Ensembl chr16:27,126,734...27,421,449
G
GRIN1
glutamate ionotropic receptor NMDA type subunit 1
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19761817
RGD:2325954
G
GRIN2A
glutamate ionotropic receptor NMDA type subunit 2A
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19761817
RGD:2325954
NCBI chr 3:32,749,329...33,149,350
Ensembl chr 3:32,750,700...33,143,499
G
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19761817
RGD:2325954
NCBI chr 5:58,477,862...58,948,735
Ensembl chr 5:58,480,528...58,927,558
G
GSN
gelsolin
severity
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:29466895
RGD:329333029
NCBI chr 1:261,295,711...261,372,848
Ensembl chr 1:261,307,008...261,372,848
G
HCN1
hyperpolarization activated cyclic nucleotide gated potassium channel 1
ISO
mRNA:decreased expression:hippocampus,cortex:
RGD
PMID:19892002
RGD:9686395
NCBI chr16:29,439,294...29,808,855
Ensembl chr16:29,439,264...29,808,993
G
HDAC3
histone deacetylase 3
ISO
protein:decreased expression:brain:
RGD
PMID:23716065
RGD:9588620
NCBI chr 2:143,273,188...143,287,421
Ensembl chr 2:143,273,192...143,287,399
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:brain (rat) mRNA, protein:increased expression:brain,kidney (rat)
RGD CTD
PMID:18210138 PMID:19595151 PMID:23694759 PMID:31784544
RGD:155882534 RGD:9068873 RGD:9068901
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HMOX1
heme oxygenase 1
treatment
ISO
RGD
PMID:25447631
RGD:10766440
G
IGF1
insulin like growth factor 1
treatment
ISO
RGD
PMID:11672597 PMID:19766709 PMID:23694759
RGD:10046049 RGD:12904932 RGD:8549456
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
IGF2
insulin like growth factor 2
disease_progression
ISO
RGD
PMID:16787587
RGD:5510005
NCBI chr 2:1,469,183...1,496,417
G
IGFBP3
insulin like growth factor binding protein 3
ISO
RGD
PMID:10709766
RGD:10402756
NCBI chr18:50,002,921...50,009,425
Ensembl chr18:50,003,022...50,010,690
G
IL6
interleukin 6
severity
ISO
DNA:polymorphism: :174G>C(human)
RGD
PMID:22117975
RGD:12792241
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
INHBA
inhibin subunit beta A
treatment severity
ISO
mRNA:increased expression:brain (rat) human construct in rat model mRNA, protein:increased expression:umbilical cord blood (human)
RGD
PMID:10415398 PMID:27957679
RGD:329322882 RGD:329849106
NCBI chr12:53,115,379...53,117,128 NCBI chr18:52,889,684...52,909,260
Ensembl chr18:52,889,684...52,900,967
G
IRAK1
interleukin 1 receptor associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21925238
NCBI chr X:124,717,604...124,724,855
Ensembl chr X:124,717,612...124,724,860
G
IRAK4
interleukin 1 receptor associated kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21925238
NCBI chr 5:74,842,184...74,858,125
Ensembl chr 5:74,834,600...74,859,344
G
IREB2
iron responsive element binding protein 2
ISO
mRNA:increased expression:brain (rat)
RGD
PMID:27602087
RGD:12903962
NCBI chr 7:47,481,539...47,529,199
Ensembl chr 7:47,478,706...47,529,242
G
KDR
kinase insert domain receptor
ISO
RGD
PMID:21277350
RGD:5684383
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
LOC110258578
interleukin-1 beta-like
ISO
protein:increased expression:brain (rat)
RGD
PMID:23110519
RGD:7204438
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
ISO
RGD
PMID:25919564
RGD:11558017
NCBI chr17:37,957,830...37,959,505
Ensembl chr17:37,957,507...37,959,505
G
MAP2
microtubule associated protein 2
ISO
RGD
PMID:21300124
RGD:6483088
NCBI chr15:112,156,578...112,462,932
Ensembl chr15:112,236,119...112,462,929
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
ISO
RGD
PMID:21843499
RGD:9587791
NCBI chr 1:27,380,143...27,600,500
Ensembl chr 1:27,380,142...27,600,493
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
ameliorates
ISO
protein:increased expression:brain (rat)
RGD
PMID:29138854 PMID:32734729
RGD:155804273 RGD:155804275
NCBI chr 1:58,482,046...58,548,087
Ensembl chr 1:58,481,956...58,548,057
G
MAPT
microtubule associated protein tau
treatment
ISO
RGD
PMID:25665755
RGD:13782373
NCBI chr12:17,098,259...17,211,483
Ensembl chr12:17,095,587...17,211,373
G
MBD2
methyl-CpG binding domain protein 2
ISO
protein:increased expression:brain:
RGD
PMID:23716065
RGD:9588620
NCBI chr 1:103,683,077...103,768,372
Ensembl chr 1:103,735,192...103,752,402
G
MBP
myelin basic protein
ISO
protein:decreased expression:white matter:
RGD
PMID:23715956
RGD:7327196
NCBI chr 1:147,649,516...147,685,289
Ensembl chr 1:147,590,865...147,685,290
G
MIR140
microRNA mir-140
severity
ISO
miRNA:decreased expression:blood serum (human)
RGD
PMID:34331407
RGD:329347831
NCBI chr 6:17,077,530...17,077,599
Ensembl chr 6:17,077,507...17,077,620
G
MIR17
microRNA mir-17
ISO
RGD
PMID:35085690
RGD:329349305
NCBI chr11:60,734,656...60,734,732
Ensembl chr11:60,734,656...60,734,732
G
MIR374A
microRNA mir-374a
severity
ISO
miRNA:decreased expression:blood serum (human)
RGD
PMID:29568675
RGD:155598592
NCBI chr X:59,602,875...59,602,954
Ensembl chr X:59,602,875...59,602,954
G
MPO
myeloperoxidase
ISO
protein:increased activity:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
G
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23694759
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
NRF1
nuclear respiratory factor 1
ISO
mRNA, protein:increase expression:cerebral cortex
RGD
PMID:18723421
RGD:2302400
NCBI chr18:19,008,408...19,142,678
Ensembl chr18:18,998,930...19,142,628
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
mRNA:increased expression:brain
RGD
PMID:19633950
RGD:5684358
NCBI chr 4:93,219,509...93,237,944
Ensembl chr 4:93,219,516...93,255,981
G
PDGFB
platelet derived growth factor subunit B
ISO
RGD
PMID:10215166
RGD:10449494
Ensembl chr 5:8,986,462...9,007,435
G
PLAT
plasminogen activator, tissue type
onset
ISO
RGD
PMID:18467699
RGD:6483831
NCBI chr17:11,195,599...11,223,821
Ensembl chr17:11,195,602...11,224,032
G
PLAU
plasminogen activator, urokinase
ISO
mRNA, protein:increased expression, increased activity:hippocampus (rat)
RGD
PMID:18467699 PMID:19587273
RGD:2316117 RGD:6483831
NCBI chr14:76,629,313...76,635,173
Ensembl chr14:76,629,299...76,635,172
G
PPP1R1B
protein phosphatase 1 regulatory inhibitor subunit 1B
ISO
RGD
PMID:23153068
RGD:13515077
NCBI chr12:22,681,244...22,690,978
Ensembl chr12:22,680,980...22,690,952
G
PRKDC
protein kinase, DNA-activated, catalytic subunit
treatment
ISO
RGD
PMID:30485360
RGD:39938998
NCBI chr 4:79,687,375...79,850,146
Ensembl chr 4:79,687,375...79,846,656
G
PTPN5
protein tyrosine phosphatase non-receptor type 5
ISO
STEP33;protein:increased expression:forebrain (rat)
RGD
PMID:10537057
RGD:9835021
NCBI chr 2:40,458,865...40,521,470
Ensembl chr 2:40,459,049...40,521,461
G
PTPRZ1
protein tyrosine phosphatase receptor type Z1
ISO
RGD
PMID:16041802
RGD:9590116
NCBI chr18:25,046,027...25,228,276
Ensembl chr18:25,045,742...25,168,053
G
RNF146
ring finger protein 146
ISO
RGD
PMID:28108258
RGD:13524865
NCBI chr 1:35,909,789...35,927,265
Ensembl chr 1:35,909,575...35,926,968
G
ROBO1
roundabout guidance receptor 1
exacerbates
ISO
RGD
PMID:31356825
RGD:242905191
NCBI chr13:175,348,223...176,479,482
Ensembl chr13:175,348,410...176,479,481
G
S100B
S100 calcium binding protein B
severity
ISO
associated with Asphyxia Neonatorum;protein:increased expression:urine protein:increased expression:blood serum (human)
RGD
PMID:14707571 PMID:29568675
RGD:155598592 RGD:5508819
G
SERPINE1
serpin family E member 1
ISO
RGD
PMID:19587273
RGD:2316117
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
SLC9A1
solute carrier family 9 member A1
ISO
RGD
PMID:20883671
RGD:6771331
NCBI chr 6:84,373,921...84,426,447
Ensembl chr 6:84,372,649...84,426,997
G
SLIT2
slit guidance ligand 2
treatment
ISO
RGD
PMID:31356825
RGD:242905191
NCBI chr 8:14,758,426...15,149,515
Ensembl chr 8:14,758,335...15,148,133
G
SPI1
Spi-1 proto-oncogene
ISO
protein:increased expression:CA1 field of hippocampus
RGD
PMID:10713349
RGD:9586724
NCBI chr 2:15,227,850...15,245,679
Ensembl chr 2:15,227,881...15,245,677
G
SRGAP1
SLIT-ROBO Rho GTPase activating protein 1
exacerbates
ISO
RGD
PMID:31356825
RGD:242905191
NCBI chr 5:28,300,955...28,605,122
Ensembl chr 5:28,300,950...28,605,120
G
TERT
telomerase reverse transcriptase
treatment
ISO
RGD
PMID:21940960
RGD:11038672
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
G
TF
transferrin
treatment
ISO
RGD
PMID:22736466
RGD:7244383
NCBI chr13:74,930,655...74,970,599
Ensembl chr13:74,930,655...74,972,763
G
TFAM
transcription factor A, mitochondrial
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:18723421
RGD:2302400
NCBI chr14:92,261,713...92,279,731
Ensembl chr14:92,259,403...92,279,731
G
TLR2
toll like receptor 2
ISO
RGD
PMID:28139935
RGD:15090829
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
G
TRPC6
transient receptor potential cation channel subfamily C member 6
ISO
mRNA:increased expression:glomerular podocytes (rat)
RGD
PMID:31784544
RGD:155882534
NCBI chr 9:32,332,768...32,439,184
Ensembl chr 9:32,332,771...32,439,184
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23694759
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
ZEB2
zinc finger E-box binding homeobox 2
ISO
mRNA:increased expression:glomerular podocytes (rat)
RGD
PMID:31784544 PMID:34852714
RGD:155882534 RGD:155882542
NCBI chr15:7,498,879...7,631,347
Ensembl chr15:7,499,026...7,632,655
G
PNPO
pyridoxamine 5'-phosphate oxidase
ISO
ClinVar Annotator: match by term: Pyridoxal phosphate-responsive seizures
OMIM ClinVar
PMID:9536098 PMID:15182361 PMID:15772097 PMID:16199547 PMID:17216302 PMID:17576681 PMID:18296573 PMID:18485777 PMID:19759001 PMID:20370816 PMID:21292558 PMID:22858719 PMID:23419474 PMID:23430561 PMID:23708187 PMID:24266778 PMID:24297574 PMID:24645144 PMID:24658933 PMID:24781210 PMID:25256445 PMID:25741868 PMID:25762494 PMID:25979913 PMID:26467025 PMID:27014579 PMID:27419045 PMID:27781031 PMID:28133863 PMID:28349276 PMID:28492532 PMID:28929476 PMID:28985901 PMID:29588952 PMID:29610166 PMID:31440721 PMID:32395712 PMID:32788630 PMID:32888189 PMID:33087887 PMID:33981986 PMID:34177756 PMID:34769443 PMID:35217610 PMID:35495162 PMID:35636100 PMID:35715422 PMID:36007526 PMID:36106796 PMID:36801247 More...
NCBI chr12:24,192,848...24,201,419
Ensembl chr12:24,192,897...24,201,411
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all